Nanjing Medical University First Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication

Early Phase 1

Not yet recruiting

Conditions: Helicobacter Pylori Infection

Interventions: Drug: Vonoprazan
Drug: Amoxicillin
Drug: Banxiaxiexin decotion

First Posted Date: 2024-04-01

Last Posted Date: 2024-04-01

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 100

Registration Number: NCT06340724

Locations: 🇨🇳
Nanjing First Hospitai, Nanjing, Jiangsu, China

Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study

Not Applicable

Not yet recruiting

Conditions: Furazolidone
Helicobacter Pylori Infection
Tegoprazan

Interventions: Biological: Tegoprazan-amoxicillin dual therapy

First Posted Date: 2024-04-01

Last Posted Date: 2024-04-01

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 600

Registration Number: NCT06340334

Effects of Inclisiran Combined with Statins on the Morphology of Coronary Vulnerable Plaques

Phase 4

Recruiting

Conditions: Coronary Artery Disease

Interventions: Drug: Inclisiran sodium
Drug: Rosuvastatin

First Posted Date: 2024-03-29

Last Posted Date: 2025-02-14

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 40

Registration Number: NCT06338293

Locations: 🇨🇳
NanJing Frist Hospital, Nanjing, Jiangsu, China

Effects of Coffee Consumption on Metabolic Markers in Adults With Prediabetes and Obesity

Not Applicable

Recruiting

Conditions: Prediabetes

Interventions: Dietary Supplement: Coffee capsule
Dietary Supplement: Corn starch capsule

First Posted Date: 2024-03-26

Last Posted Date: 2024-03-26

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 100

Registration Number: NCT06330727

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Research on Precision Pharmaceutical Care for Heart Transplant Recipients

Active, not recruiting

Conditions: Heart Transplant Patients

First Posted Date: 2024-03-22

Last Posted Date: 2024-03-22

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 500

Registration Number: NCT06326775

Locations: 🇨🇳
Pharmacy Department of Nanjing First Hospital, Nanjing, Jiangsu, China

Pulmonary Arteyr Denervation for HF Without PH

Active, not recruiting

Conditions: Heart Failure

First Posted Date: 2024-03-21

Last Posted Date: 2025-03-17

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 20

Registration Number: NCT06323512

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Please Select, China

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

Phase 2

Recruiting

Conditions: Gastrointestinal Neoplasms

Interventions: Drug: Envafolimab Injection
Drug: Endostar

First Posted Date: 2024-03-08

Last Posted Date: 2024-03-08

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 16

Registration Number: NCT06301828

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea

Not Applicable

Recruiting

Conditions: Rosacea
Botulinum Toxin

Interventions: Drug: Botulinum Toxin Type A Injection [Botox]

First Posted Date: 2024-02-28

Last Posted Date: 2024-02-28

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 30

Registration Number: NCT06282679

Locations: 🇨🇳
Jie Dai, Nanjing, Jiangsu, China

Clinical Observation of Exosomes in Patients After Q-switched Laser Surgery

Not Applicable

Recruiting

Conditions: Laser
Exosome
Skin Regeneration

Interventions: Drug: Exosome liquid dressing

First Posted Date: 2024-02-26

Last Posted Date: 2024-02-26

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 38

Registration Number: NCT06279039

Locations: 🇨🇳
Jie Dai, Nanjing, Jiangsu, China

Corheart 6 LVAS Long-term Follow-up Study

Not Applicable

Not yet recruiting

Conditions: Heart Failure

Interventions: Device: Corheart 6 Left Ventricular Assist System

First Posted Date: 2024-02-20

Last Posted Date: 2024-02-20

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 30

Registration Number: NCT06267612

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Home Terms & Conditions Privacy Policy